Evidence map›Paper›PMID 40668360›Full record

ArticleCalcified tissue international2025

Blockade of Gi Signaling Enhances the Anabolic Effect of Parathyroid Hormone in Female Mice.

Liping Wang, Lalita Wattanachanya, Vikrant Piprode, Robert A Nissenson

Abstract read
In one paragraph

Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liping WangEndocrine Research Unit, VA Medical Center, San Francisco, CA, USA.
Lalita WattanachanyaEndocrine Research Unit, VA Medical Center, San Francisco, CA, USA.
Vikrant PiprodeEndocrine Research Unit, VA Medical Center, San Francisco, CA, USA.
Robert A NissensonEndocrine Research Unit, VA Medical Center, San Francisco, CA, USA. Robert.Nissenson@ucsf.edu.ORCID http://orcid.org/0000-0002-0701-0151

Funding

Skeletal Biology and Biomechanics (SBB) CoreP30AR075055 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARD C HSIAO · 2019 to 2026
$7.1M
Novel Strategies for Understanding and Treating Fibrous DysplasiaR01AR081336 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARD C HSIAO, Robert Nissenson · 2023 to 2026
$2.7M
NIAMS NIH HHS 1R01AR081336NIAMS NIH HHS P30 AR075055NIAMS NIH HHS R01 AR081336U.S. Department of Veterans Affairs 2I0BX003213
6 · The paper itself

Abstract

Intermittent administration of parathyroid hormone (PTH) produces potent anabolic effects on bone. These anabolic effects appear to be mediated by activation of the Gs-cyclic AMP system initiated by the PTH1 receptor (PTHR1) in osteoblast lineage cells. Gs-mediated cyclic AMP production can be inhibited by activation of Gi signaling, and we have previously demonstrated that Gi signaling in osteoblasts suppresses bone formation and thereby plays a prominent role in the bone loss associated with aging in female mice. It is not clear whether this increased Gi signaling with aging dampens the anabolic response to intermittent PTH (iPTH) administration. To address this possibility, we determined the effect of inducible blockade of Gi signaling in osteoblasts on the anabolic response to PTH in 4-month-old female mice. Blockade of Gi signaling was achieved by tetracycline-regulated expression of pertussis toxin (PTX) driven by a Col1(2.3) promoter. We found that the expression of PTX potentiated the anabolic effect of iPTH on the trabecular bone, both at the distal femur and L4 lumbar vertebra. In addition, the ability of PTH to promote cortical bone thickness and strength was evident only in mice expressing PTX. These novel results demonstrate that endogenous Gi signaling in osteoblasts limits the anabolic action of iPTH on the skeleton of adult female mice. Strategies that suppress osteoblast Gi signaling could provide an effective adjunct to iPTH therapy in the treatment of postmenopausal osteoporosis.

Indexed as

Anabolic AgentsGTP-Binding Protein alpha Subunits, Gi-GoParathyroid HormoneSignal TransductionAnimalsBone and BonesBone DensityFemaleMiceOsteoblastsOsteogenesisReceptor, Parathyroid Hormone, Type 1Anabolic AgentsGTP-Binding Protein alpha Subunits, Gi-GoParathyroid HormoneReceptor, Parathyroid Hormone, Type 1AnabolicAnabolic actionBoneGi signalingGPCRG protein-coupled receptorParathyroid hormonePTH

Identifiers

PMID40668360
PMCPMC12267360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.